Attached files

file filename
10-Q/A - QUARTERLY REPORT AMENDMENT - China BCT Pharmacy Group, Inc.f10q0911a1_chinabct.htm
EX-31.1 - RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CHIEF EXECUTIVE OFFICER - China BCT Pharmacy Group, Inc.f10q0911a1ex31i_chinabct.htm
EX-31.2 - RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CHIEF FINANCIAL OFFICER - China BCT Pharmacy Group, Inc.f10q0911a1ex31ii_chinabct.htm
Exhibit 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350 AND EXCHANGE ACT RULES 13a-14(b) AND 15d-14(b)
(Section 906 of the Sarbanes-Oxley Act of 2002)
 
In connection with the Quarterly Report of China BCT Pharmacy Group, Inc. on Form 10-Q/A for the period ended September 30, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned does hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his or her knowledge and belief:
 
(1)           the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)           the information contained in the Report fairly presents, in all material respects, the financial condition and results of the operation of the Company.

   
Dated: November 15, 2011
 
 
By:
/s/ Huitian Tang
   
Huitian Tang
   
Chief Executive Officer and Chairman
     

Dated: November 15, 2011
 
 
By:
/s/ Xiaoyan Zhang
   
Xiaoyan Zhang
   
Chief Financial Officer